Health In Tech reports Q2 2026 revenue, reaffirms guidance
Health In Tech (NASDAQ: HIT) reported Q2 2026 GAAP revenue of $8.1 million versus $9.3 million a year ago, posted negative adjusted EBITDA of $1.3 million, and reaffirmed full-year 2026 revenue guidance of $45 million to $50 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.